Literature DB >> 1570151

No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.

W Warren1, R A Eeles, B A Ponder, D F Easton, D Averill, M A Ponder, K Anderson, A M Evans, R DeMars, R Love.   

Abstract

Recent studies have demonstrated that families with the Li-Fraumeni syndrome carry inherited point mutations of the p53 gene. In the present study 25 families with strong histories of breast cancer were screened for the presence of such mutations. Polymerase chain reaction products of exons 5-9 of the p53 gene were examined by single-stranded conformational polymorphism analysis and, in addition, exon 7 was further screened by direct sequencing. No mutations were detected in constitutive DNA by either method. These results indicate that familial breast cancer does not usually result from germline point mutations in the p53 gene.

Entities:  

Mesh:

Year:  1992        PMID: 1570151

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

Review 2.  Molecular genetics of familial breast-ovarian cancer.

Authors:  E J van Rensburg; B A Ponder
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

Review 3.  The contribution of inherited factors to the clinicopathological features and behavior of breast cancer.

Authors:  W D Foulkes; J Rosenblatt; P O Chappuis
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

4.  William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer.

Authors:  R M Elledge; S A Fuqua; G M Clark; P Pujol; D C Allred
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.

Authors:  A Weston; J H Godbold
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

6.  The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia.

Authors:  A Marsh; A B Spurdle; B C Turner; S Fereday; H Thorne; G M Pupo; G J Mann; J L Hopper; J F Sambrook; G Chenevix-Trench
Journal:  Breast Cancer Res       Date:  2001-07-17       Impact factor: 6.466

7.  Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England.

Authors:  H S Evans; C M Lewis; D Robinson; C M Bell; H Møller; S V Hodgson
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

8.  Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.

Authors:  A H McCann; A Kirley; D N Carney; N Corbally; H M Magee; G Keating; P A Dervan
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

9.  Linkage analysis of BRCA1 in Japanese breast cancer families.

Authors:  R Inoue; T Fukutomi; T Ushijima; Y Matsumoto; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.